Table 2.
Diabetic biomarkers and vitamin D level of the participants (N = 150).
| Parameters | Groups | ||||
|---|---|---|---|---|---|
| Control group | Type 1 diabetic patients | Type 1 diabetic patients with COVID-19 | Test value | p value | |
| FBG (mmol/l) | 5.28 ± 0.72 | 15.81 ± 2.51a | 19.12 ± 2.42ab | 606.087 | <0.001 |
| HbA1c (%) | 5.69 ± 0.39 | 9.4 ± 1.02a | 10.8 ± 0.97ab | 476.234 | <0.001 |
| Vitamin D (IU) | 97.23 ± 20.35 | 64.98 ± 8.44a | 53.93 ± 11.91ab | 118.585 | <0.001 |
Results are expressed as mean ± SD. FBG: fasting blood glucose; HbA1c: glycated hemoglobin. aSignificantly different from the control group. bSignificantly different from the type 1 diabetic patients. p < 0.05 is considered significant.